Recognition and Prevention Program
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
The Recognition and Prevention (RAP) Program is a research and specialty clinic located in the Zucker Hillside Hospital in Glen Oaks, New York.[citation needed] It provides education and treatment for young people and their families, and conducts research about the effects of early identification in preventing the progression of serious mental illnesses. The program’s approach is that, with early intervention, an individual’s chances of remaining in school, working, maintaining friendships, and planning for the future might be significantly improved .[1][2][3][4][5][6][7]
History
The RAP Program was founded by its Director, Dr. Barbara A. Cornblatt, in 1998 and was one of the first programs in North America to investigate and treat the prodromal or pre-psychotic phases of Schizophrenia and Bipolar Disorder.[8][citation needed] Since its inception, over 250 adolescents and young adults, ages 12–22, have participated in the RAP clinic and research program.
RAP is funded by the Robert Wood Johnson Foundation and the National Institute of Mental Health, and is part of the North American Prodromal Longitudinal Study (NAPLS), a consortium of eight prodromal programs which constitutes one of the leading investigations[citation needed] of the biological, behavioral and functional attributes of the psychosis prodrome worldwide.[9]
References
- ^ http://www.rapprogram.org/aboutRAP.html
- ^ Cornblatt, B.A. & Keilp, J.G. (1994). Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophrenia Bulletin, 20(1):31-46
- ^ Cornblatt, B.A., Lencz, T., Smith, C.W., Correll, C.U., Auther, A.M., Nakayama, E. (2003). The schizophrenia prodrome revisited: A neurodevelopmental perspective. Schizophrenia Bulletin, 29(4):633-651
- ^ Cornblatt, B.A & Auther, A.M. (2005). Treating early psychosis: Who, what, and when? Dialogues in clinical neuroscience, 7(1):39-49
- ^ Cornblatt, B.A., Lencz, T., Smith, C.W., Olsen, R., Auther, A.M., Nakayama, E., et al. (2007). Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents. Journal of Clinical Psychiatry, 68(4):546-557
- ^ Cornblatt, B.A, Auther, A.M., Niendam, T., Smith, C.W., Zinberg, J., Bearden, C.E., Cannon, T.D. (2007). Premlinary findings for two new measures of social and role functioning in the prodromal phase of schizphrenia.[citation needed] Schizophrenia Bulletin, 33(3):688-702
- ^ Auther, A.M., Gillett, D.A. & Cornblatt, B.A. (2008). Expanding the boundaries of early intervention for psychosis: Intervening during the prodrome. Psychiatric Annals, 38(8):528-537
- ^ http://www.feinsteininstitute.org/Feinstein/Program+for+Recognition+and+Prevention
- ^ Cannon, T.D., Cadenhead, K., Cornblatt, B., Woods, S.W., Addington, J., Walker, E., Seidman, L.J., Perkins, D., Tsuang, M., McGlashan, T., & Heinssen, R. (2008). Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Archives of General Psychiatry, 65(1):28-37.